Dr. Michelle Bradley focuses her work on patent drafting and IP due diligence inquiries, including freedom-to-operate and patentability analyses, with an emphasis on biotechnology and pharmaceuticals. Areas of her research included chemistry, biochemistry, and mitochondrial metabolism.

Michelle earned her Ph.D. and M.S. in Biochemistry, Molecular and Structural Biology from the University of California, Los Angeles (UCLA). She focused her doctoral research on the characterization of Coq11, a novel protein involved in the biosynthesis of coenzyme Q in Saccharomyces cerevisiae. Other predoctoral training included designing CRISPR knockout constructs in zebrafish, understanding the effect of nutrient sensor genes on coenzyme Q biosynthesis, and studying early mitotic spindle assembly.

Michelle received her B.A. in Biochemistry from Colgate University, where she studied the organic synthesis of porphyrins. Her undergraduate studies also included triple negative breast cancer genotyping led at the National Institutes of Health (NIH), National Cancer Institute.

Michelle’s honors and awards include the Robert A. Smith Dissertation Award from UCLA, and the Ruth L. Kirschstein Predoctoral Individual National Research Service Award from the NIH.